Search research articles
Contact Us
Filters
Showing results (31-40 of 212) with videos related to
Page
of 22
Sort By:
Cancers
|
February 13, 2026
Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center Experience
Ichrak Ben Abdallah, Severine Guiu, Xavier Quantin, et al.
Cancers
|
June 2, 2021
CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
Florence Boissière-Michot, William Jacot, Océane Massol, et al.
Expert Review of Proteomics
|
June 15, 2006
Clinical proteomics and mass spectrometry profiling for cancer detection
Jérôme Solassol, William Jacot, Ludovic Lhermitte, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2010
Anti-HER2 vaccines: new prospects for breast cancer therapy
Maha Zohra Ladjemi, William Jacot, Thierry Chardès, et al.
British Journal of Clinical Pharmacology
|
February 18, 2022
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort
Clément Carbasse, Fanny Leenhardt, William Jacot, et al.
Annales De Biologie Clinique
|
July 17, 2012
[Iron metabolism in breast cancer: knowledge and future]
Anna Durigova, William Jacot, Stéphane Pouderoux, et al.
Cancers
|
July 31, 2020
Prognostic Value of CXCR2 in Breast Cancer
Florence Boissière-Michot, William Jacot, Julien Fraisse, et al.
The Journal of Allergy and Clinical Immunology
|
January 10, 2004
Allergic rhinitis: a disease remodeling the upper airways?
Jean Bousquet, William Jacot, A Maurizio Vignola, et al.
BMC Cancer
|
February 12, 2013
Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
Antoine-Laurent Braccini, David Azria, Simon Thezenas, et al.
Critical Reviews in Oncology/Hematology
|
August 18, 2014
Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
Séverine Guiu, Anita Wolfer, William Jacot, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 212) with videos related to
Sort By:
Page
of 22
Cancers
|
February 13, 2026
Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center Experience
Ichrak Ben Abdallah, Severine Guiu, Xavier Quantin, et al.
Cancers
|
June 2, 2021
CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
Florence Boissière-Michot, William Jacot, Océane Massol, et al.
Expert Review of Proteomics
|
June 15, 2006
Clinical proteomics and mass spectrometry profiling for cancer detection
Jérôme Solassol, William Jacot, Ludovic Lhermitte, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2010
Anti-HER2 vaccines: new prospects for breast cancer therapy
Maha Zohra Ladjemi, William Jacot, Thierry Chardès, et al.
British Journal of Clinical Pharmacology
|
February 18, 2022
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort
Clément Carbasse, Fanny Leenhardt, William Jacot, et al.
Annales De Biologie Clinique
|
July 17, 2012
[Iron metabolism in breast cancer: knowledge and future]
Anna Durigova, William Jacot, Stéphane Pouderoux, et al.
Cancers
|
July 31, 2020
Prognostic Value of CXCR2 in Breast Cancer
Florence Boissière-Michot, William Jacot, Julien Fraisse, et al.
The Journal of Allergy and Clinical Immunology
|
January 10, 2004
Allergic rhinitis: a disease remodeling the upper airways?
Jean Bousquet, William Jacot, A Maurizio Vignola, et al.
BMC Cancer
|
February 12, 2013
Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
Antoine-Laurent Braccini, David Azria, Simon Thezenas, et al.
Critical Reviews in Oncology/Hematology
|
August 18, 2014
Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
Séverine Guiu, Anita Wolfer, William Jacot, et al.
Page
of 22